Overview

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

Status:
NOT_YET_RECRUITING
Trial end date:
2027-02-20
Target enrollment:
Participant gender:
Summary
The object of this study is to observe the safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome, consisting with two phases.
Phase:
PHASE1
Details
Lead Sponsor:
Southeast University, China
Collaborators:
Yinguan Biologics, Shenzheng
Zhongda Hospital
Treatments:
Carboxylesterase